Breaking News Instant updates and real-time market news.

ALL

Allstate

$101.90 /

+1.48 (+1.47%)

16:24
05/05/20
05/05
16:24
05/05/20
16:24

Allstate reports Q1 adjusted EPS $3.54, consensus $3.50

Reports Q1 revenue $10.08B, consensus $9.18B. "Allstate's proactive risk and return management served customers and shareholders exceptionally well as the coronavirus pandemic hit our shores. After 89 years in the catastrophe business, we know success is determined by acting decisively, quickly and putting people first," said Tom Wilson, Chair, President and CEO of The Allstate Corporation. "We led the industry in helping customers, including providing a Shelter-in-Place Payback of over $600 million since they are driving less due to social distancing requirements. Our employees and agents reacted quickly, with over 95% working from home to serve customers. Allstate Identity Protection is also providing free identity protection to any U.S. resident for the rest of the year. Public equity holdings were reduced in February by $4 billion as we adjusted our risk and return profile, which lowered the negative impact of the March equity market decline."

  • 06

    May

  • 19

    May

ALL Allstate
$101.90 /

+1.48 (+1.47%)

04/21/20 Raymond James
Allstate price target raised to $120 from $110 at Raymond James
04/20/20 SunTrust
Valvoline price target lowered to $16 from $23 at SunTrust
04/13/20 Evercore ISI
Allstate upgraded to Outperform from In Line at Evercore ISI
04/03/20 Raymond James
Allstate price target lowered to $110 from $145 at Raymond James

TODAY'S FREE FLY STORIES

Initiation
Chembio Diagnostics initiated with an Outperform at Baird » 05:20
05/26/20
05/26
05:20
05/26/20
05:20
CEMI

Chembio Diagnostics

$10.86 /

+0.65 (+6.37%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CEMI Chembio Diagnostics
$10.86 /

+0.65 (+6.37%)

CEMI Chembio Diagnostics
$10.86 /

+0.65 (+6.37%)

04/23/20 Craig-Hallum
Chembio Diagnostics price target raised to $21 from $15 at Craig-Hallum
12/16/19 Canaccord
Chembio Diagnostics weakness a buying opportunity, says Canaccord
07/09/19 Benchmark
Alibaba, Take-Two among Benchmark's Best Ideas for second half
06/17/19 Benchmark
Chembio Diagnostics price target lowered to $9 from $14 at Benchmark
CEMI Chembio Diagnostics
$10.86 /

+0.65 (+6.37%)

CEMI Chembio Diagnostics
$10.86 /

+0.65 (+6.37%)

Downgrade
Equinor downgraded to Sector Perform from Outperform at RBC Capital » 05:20
05/26/20
05/26
05:20
05/26/20
05:20
EQNR

Equinor

$14.81 /

-0.25 (-1.66%)

RBC Capital analyst Biraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQNR Equinor
$14.81 /

-0.25 (-1.66%)

EQNR Equinor
$14.81 /

-0.25 (-1.66%)

05/13/20 Redburn
Equinor upgraded to Buy from Neutral at Redburn
05/12/20 RBC Capital
RBC updates estimates on Equinor after Q1 results
04/29/20 Danske Bank
Equinor downgraded to Sell from Hold at Danske Bank
04/24/20 DZ Bank
Equinor downgraded to Sell from Hold at DZ Bank
EQNR Equinor
$14.81 /

-0.25 (-1.66%)

Hot Stocks
Chi-Med, BeiGene enter clinical collaboration » 05:19
05/26/20
05/26
05:19
05/26/20
05:19
HCM

Hutchison China MediTech

$21.41 /

-0.67 (-3.03%)

, BGNE

BeiGene

$159.40 /

-5.55 (-3.36%)

Hutchison China MediTech,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCM Hutchison China MediTech
$21.41 /

-0.67 (-3.03%)

BGNE BeiGene
$159.40 /

-5.55 (-3.36%)

HCM Hutchison China MediTech
$21.41 /

-0.67 (-3.03%)

03/13/20
Fly Intel: Top analyst initiations
03/12/20 Cantor Fitzgerald
Hutchison China MediTech initiated with an Overweight at Cantor Fitzgerald
02/20/20
Fly Intel: Top five analyst initiations
02/20/20 Goldman Sachs
Hutchison China MediTech initiated with a Buy at Goldman Sachs
BGNE BeiGene
$159.40 /

-5.55 (-3.36%)

03/25/20 Piper Sandler
BeiGene Abraxane issue could take months to resolve, says Piper Sandler
03/13/20 Macquarie
BeiGene upgraded to Neutral from Underperform at Macquarie
03/03/20 Maxim
BeiGene price target lowered to $190 from $210 at Maxim
02/18/20 Goldman Sachs
BeiGene reinstated with a Buy at Goldman Sachs
BGNE BeiGene
$159.40 /

-5.55 (-3.36%)

BGNE BeiGene
$159.40 /

-5.55 (-3.36%)

Downgrade
Salmar downgraded to Hold from Buy at Berenberg » 05:18
05/26/20
05/26
05:18
05/26/20
05:18
SALRF

Salmar

$0.00 /

+ (+0.00%)

Berenberg analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SALRF Salmar
$0.00 /

+ (+0.00%)

05/20/20 DNB Markets
Salmar downgraded to Hold from Buy at DNB Markets
03/26/20 Berenberg
Salmar price target lowered to NOK 405 from NOK 480 at Berenberg
02/27/20 Pareto
Salmar upgraded to Buy from Hold at Pareto
11/29/19 DNB Markets
Salmar upgraded to Buy from Hold at DNB Markets
Downgrade
Capitala downgraded to Underperform from Market Perform at JMP Securities » 05:17
05/26/20
05/26
05:17
05/26/20
05:17
CPTA

Capitala Finance

$2.69 /

+0.15 (+5.91%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPTA Capitala Finance
$2.69 /

+0.15 (+5.91%)

CPTA Capitala Finance
$2.69 /

+0.15 (+5.91%)

10/20/19 Keefe Bruyette
Capitala downgraded to Underperform from Market Perform at Keefe Bruyette
08/06/19
Capitala Finance downgraded to Neutral after quarterly results at Ladenburg
08/06/19 Ladenburg
Capitala Finance downgraded to Neutral from Buy at Ladenburg
CPTA Capitala Finance
$2.69 /

+0.15 (+5.91%)

Upgrade
Cree upgraded to Outperform from Market Perform at JMP Securities » 05:17
05/26/20
05/26
05:17
05/26/20
05:17
CREE

Cree

$51.74 /

+0.75 (+1.47%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CREE Cree
$51.74 /

+0.75 (+1.47%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

05/20/20
Fly Intel: Top five analyst upgrades
05/20/20 JPMorgan
JPMorgan upgrades Cree to Neutral, boosts target to $60 from $40
05/20/20 JPMorgan
Cree upgraded to Neutral from Underweight at JPMorgan
04/30/20 Roth Capital
Cree price target raised to $55 from $50 at Roth Capital
CREE Cree
$51.74 /

+0.75 (+1.47%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

Downgrade
Carl Zeiss Meditec downgraded to Reduce from Hold at Commerzbank » 05:16
05/26/20
05/26
05:16
05/26/20
05:16
CZMWY

Carl Zeiss Meditec

$0.00 /

+ (+0.00%)

Commerzbank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CZMWY Carl Zeiss Meditec
$0.00 /

+ (+0.00%)

05/12/20 Deutsche Bank
Deutsche Bank backs Buy on Carl Zeiss Meditec after Q2 results
Downgrade
Shimano downgraded to Neutral from Outperform at Daiwa » 05:15
05/26/20
05/26
05:15
05/26/20
05:15
SMNNY

Shimano

$0.00 /

+ (+0.00%)

Daiwa analyst Satoshi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMNNY Shimano
$0.00 /

+ (+0.00%)

01/30/20 Citi
Shimano upgraded to Neutral from Sell at Citi
Downgrade
Hurricane Energy downgraded to Speculative Buy from Buy at Canaccord » 05:14
05/26/20
05/26
05:14
05/26/20
05:14
HRCXF

Hurricane Energy

$0.00 /

+ (+0.00%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRCXF Hurricane Energy
$0.00 /

+ (+0.00%)

01/13/20 BMO Capital
Hurricane Energy downgraded to Market Perform from Outperform at BMO Capital
10/10/19 Barclays
Hurricane Energy upgraded to Overweight from Equal Weight at Barclays
Upgrade
Axcelis upgraded to Buy from Neutral at B. Riley FBR » 05:13
05/26/20
05/26
05:13
05/26/20
05:13
ACLS

Axcelis

$25.01 /

+0.09 (+0.36%)

B. Riley FBR analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACLS Axcelis
$25.01 /

+0.09 (+0.36%)

ACLS Axcelis
$25.01 /

+0.09 (+0.36%)

04/02/20 DA Davidson
Axcelis downgraded to Neutral from Buy at DA Davidson
04/02/20 DA Davidson
Axcelis downgraded to Neutral from Buy at DA Davidson
03/19/20 B. Riley FBR
B. Riley FBR downgrades 10 Semiconductor names on escalating risks
03/19/20 B. Riley FBR
Axcelis downgraded to Neutral from Buy at B. Riley FBR
ACLS Axcelis
$25.01 /

+0.09 (+0.36%)

ACLS Axcelis
$25.01 /

+0.09 (+0.36%)

Downgrade
Kone OYJ downgraded to Hold from Buy at Liberum » 05:12
05/26/20
05/26
05:12
05/26/20
05:12
KNYJY

Kone OYJ

$0.00 /

+ (+0.00%)

Liberum analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KNYJY Kone OYJ
$0.00 /

+ (+0.00%)

04/27/20 Berenberg
Kone OYJ price target raised to EUR 49 from EUR 45 at Berenberg
04/24/20 UBS
Kone OYJ price target raised to EUR 53 from EUR 50 at UBS
04/23/20 Barclays
Kone OYJ price target raised to EUR 46 from EUR 40 at Barclays
04/23/20 Morgan Stanley
Kone OYJ price target raised to EUR 47 from EUR 43 at Morgan Stanley
Initiation
CIFI Holdings initiated with a Buy at China Renaissance » 05:08
05/26/20
05/26
05:08
05/26/20
05:08
CFFHF

CIFI Holdings

$0.00 /

+ (+0.00%)

China Renaissance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Flex LNG downgraded to Sell from Buy at Danske Bank » 05:07
05/26/20
05/26
05:07
05/26/20
05:07
FLNG

Flex LNG

$4.85 /

-0.12 (-2.41%)

Danske Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLNG Flex LNG
$4.85 /

-0.12 (-2.41%)

FLNG Flex LNG
$4.85 /

-0.12 (-2.41%)

03/09/20 DNB Markets
Flex LNG downgraded to Hold from Buy at DNB Markets
11/21/19 Nordea
Flex LNG downgraded to Hold from Buy at Nordea
Downgrade
Hoegh LNG Partners downgraded to Sell from Buy at Danske Bank » 05:07
05/26/20
05/26
05:07
05/26/20
05:07
HMLP

Hoegh LNG Partners

$10.44 /

-0.15 (-1.42%)

Danske Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HMLP Hoegh LNG Partners
$10.44 /

-0.15 (-1.42%)

HMLP Hoegh LNG Partners
$10.44 /

-0.15 (-1.42%)

11/22/19 DNB Markets
Hoegh LNG Partners upgraded to Hold from Sell at DNB Markets
10/29/19 Citi
Hoegh LNG Partners downgraded to Sell from Buy at Citi
10/28/19 DNB Markets
Hoegh LNG Partners downgraded to Sell from Hold at DNB Markets
HMLP Hoegh LNG Partners
$10.44 /

-0.15 (-1.42%)

Recommendations
Acceleron shares not pricing in PAH opportunity, says Piper Sandler » 05:05
05/26/20
05/26
05:05
05/26/20
05:05
XLRN

Acceleron

$98.64 /

-0.43 (-0.43%)

While Acceleron Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$98.64 /

-0.43 (-0.43%)

XLRN Acceleron
$98.64 /

-0.43 (-0.43%)

05/12/20 SVB Leerink
Acceleron price target raised to $127 from $104 at SVB Leerink
05/08/20 Credit Suisse
Acceleron price target raised to $123 from $99 at Credit Suisse
04/16/20 Citi
Citi opens 'positive 90-day catalyst watch' on Acceleron
04/06/20 Piper Sandler
Acceleron still top pick after Rebloyzl indication approval, says Piper Sandler
XLRN Acceleron
$98.64 /

-0.43 (-0.43%)

XLRN Acceleron
$98.64 /

-0.43 (-0.43%)

Recommendations
Piper Sandler encouraged by remdesivir results published in NEJM » 05:02
05/26/20
05/26
05:02
05/26/20
05:02
GILD

Gilead

$73.31 /

-0.17 (-0.23%)

The full results from the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/21/20 JPMorgan
Gilead Phase 3 ulcerative colitis study 'mixed at best,' says JPMorgan
05/13/20 Piper Sandler
KOL sees remdesivir as COVID-19 standard of care, says Piper Sandler
05/13/20 JPMorgan
Gilead already given 'ample market credit' for remdesivir, says JPMorgan
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

Recommendations
Halozyme's Enhanze business nearing accelerated growth, says Piper Sandler » 04:57
05/26/20
05/26
04:57
05/26/20
04:57
HALO

Halozyme

$24.60 /

+0.16 (+0.65%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HALO Halozyme
$24.60 /

+0.16 (+0.65%)

HALO Halozyme
$24.60 /

+0.16 (+0.65%)

05/12/20 JMP Securities
Halozyme price target raised to $34 from $24 at JMP Securities
05/04/20 Cantor Fitzgerald
Halozyme price target raised to $39 from $35 at Cantor Fitzgerald
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
02/05/20
Fly Intel: Top five analyst upgrades
HALO Halozyme
$24.60 /

+0.16 (+0.65%)

HALO Halozyme
$24.60 /

+0.16 (+0.65%)

Conference/Events
Milestone Scientific to hold a webinar » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
MLSS

Milestone Scientific

$1.87 /

+0.1 (+5.65%)

Interim CEO Osser…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MLSS Milestone Scientific
$1.87 /

+0.1 (+5.65%)

Conference/Events
Cowen biotechnology analysts to hold an analyst/industry conference call » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

Biotech Analysts Nadeau,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Alexion participates in a conference call with Credit Suisse » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
ALXN

Alexion

$101.54 /

+0.31 (+0.31%)

Management discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALXN Alexion
$101.54 /

+0.31 (+0.31%)

ALXN Alexion
$101.54 /

+0.31 (+0.31%)

05/15/20 H.C. Wainwright
H.C. Wainwright calls Sarepta 'best of breed' after Pfizer DMD data
05/06/20 Piper Sandler
Piper Sandler remains buyer of Alexion despite frustration
05/05/20 Jefferies
Jefferies sees Portola acquisition as neutral for Alexion
05/05/20 Piper Sandler
Alexion's management deserves benefit of the doubt, says Piper Sandler
ALXN Alexion
$101.54 /

+0.31 (+0.31%)

ALXN Alexion
$101.54 /

+0.31 (+0.31%)

ALXN Alexion
$101.54 /

+0.31 (+0.31%)

ALXN Alexion
$101.54 /

+0.31 (+0.31%)

Conference/Events
Cowen pharmaceuticals analyst to hold an analyst/industry conference call » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

Pharmaceuticals Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Gilead participates in a conference call with Credit Suisse » 04:55
05/26/20
05/26
04:55
05/26/20
04:55
GILD

Gilead

$73.31 /

-0.17 (-0.23%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/21/20 JPMorgan
Gilead Phase 3 ulcerative colitis study 'mixed at best,' says JPMorgan
05/13/20 Piper Sandler
KOL sees remdesivir as COVID-19 standard of care, says Piper Sandler
05/13/20 JPMorgan
Gilead already given 'ample market credit' for remdesivir, says JPMorgan
GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

GILD Gilead
$73.31 /

-0.17 (-0.23%)

General news
Dallas Fed Mfg Survey General Activity Index to be reported at 10:30 » 04:55
05/26/20
05/26
04:55
05/26/20
04:55

May Dallas Fed Mfg Survey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
4-Week Bill Announcement to be released at 11:00  04:55
05/26/20
05/26
04:55
05/26/20
04:55
 
General news
6-Month Bill Auction to be released at 11:30  04:55
05/26/20
05/26
04:55
05/26/20
04:55
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.